LifeSync
Bob Buehler has a diverse work experience spanning several companies in various roles. Bob started their career at Cargill, where they held various merchandising and management positions. In 1995, they joined Arizant Healthcare, where they served as Vice President of Marketing and Vice President of Global Sales. Bob later became President of Arizant International, managing the company's P&L and driving growth in non-US markets. In 2010, they joined 3M Healthcare through the acquisition of Arizant and held leadership positions in the Infection Prevention Division. In 2013, they became Chief Commercial Officer at RespirTech, where they significantly increased revenue and expanded key functions. In 2018, they became the CEO and Board Member of LifeSync, a company owned by HealthEdge Investment Partners. Additionally, they served on the Board of Directors for Transcend and Augustine Medical South Africa (Pty) Ltd.
Bob Buehler holds a Bachelor of Science degree in Business Administration from The Ohio State University, which they earned from 1979 to 1984. Bob later pursued a Master of Business Administration degree from the University of Minnesota - Carlson School of Management, completing it from 1992 to 1994. Currently, Bob is pursuing a Doctor of Philosophy degree in Business Administration at Florida Atlantic University, expected to be completed from 2020 to 2023.
This person is not in any offices
LifeSync
1 followers
LifeSync is a rapidly expanding Florida-based designer, contract manufacturer, and seller of patient monitoring connections and accessories for cardiac and neurological diagnostic markets. LifeSync has grown significantly in recent years, in large part, through the acquisition of established medical product providers. In 2019, LifeSync purchased American Biosurgical Inc. (ABI) and Vital Connections (VC). With the addition of ABI, LifeSync now offers comprehensive, cost-effective contract manufacturing services for OEM monitoring companies. VC provides unique design and manufacturing capabilities built around highly specialized materials and processes. VC also expands LifeSync’s radiolucent lead wire portfolio—a growing category that enables efficient throughput for patients undergoing imaging procedures like MRIs. ABI and VC join three other market-leading companies acquired since 2012 by LifeSync’s owner, HealthEdge Investment Partners. These successful strategic acquisitions allow LifeSync to deliver components that fit all monitoring systems—standardization that streamlines care, increases efficiency, and reduces costs. Today, LifeSync is a top provider of disposable ECG lead wires, which support key infection prevention initiatives. LifeSync is well-positioned to meet the increasing demands for monitoring in both existing categories like cardiac care and emerging areas, such as sleep science and wireless healthcare delivery. With more than 1,300 employees and operations in the U.S., Mexico, and China, LifeSync directly serves hospitals and health systems, and provides full contract manufacturing capabilities for diagnostic/monitoring device makers worldwide.